| 000 | 01858 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515045506.0 | ||
| 264 | 0 | _c20070215 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0957-5235 | ||
| 024 | 7 |
_a10.1097/01.mbc.0000252599.32648.35 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl Accaoui, Ramzi | |
| 245 | 0 | 0 |
_aA review of the off-label use of recombinant activated factor VII in a developing country tertiary care center. _h[electronic resource] |
| 260 |
_bBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis _cNov 2006 |
||
| 300 |
_a647-50 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAcademic Medical Centers _xstatistics & numerical data |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Loss, Surgical _xprevention & control |
| 650 | 0 | 4 |
_aCoagulants _xtherapeutic use |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aDrug Labeling |
| 650 | 0 | 4 |
_aFactor VII _xtherapeutic use |
| 650 | 0 | 4 | _aFactor VIIa |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHemostatic Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aLebanon |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPractice Patterns, Physicians' _xstatistics & numerical data |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aIsma'eel, Hussain | |
| 700 | 1 | _aKhalil, Pierre Bou | |
| 700 | 1 | _aTaher, Ali | |
| 773 | 0 |
_tBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis _gvol. 17 _gno. 8 _gp. 647-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.mbc.0000252599.32648.35 _zAvailable from publisher's website |
| 999 |
_c16675021 _d16675021 |
||